Concepedia
Statistics
Publications
12
Citations
917
H-Index
Active since
1993
Affiliations
CEA Valduc(Current)
Nova Scotia Cancer Centre
Cancer Institute (WIA)
Centre Georges François Leclerc
Hôpital Saint-Louis
J.-M. Nabholtz is an author at CEA Valduc specializing in medicine, oncology, and pharmacology.
Publications per year
1993–2018
Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer.
J.-M. Nabholtz, Karen A. Gelmon, M. Bontenbal et al. · Journal of Clinical Oncology · 1996 · 383 citations · Full text
Medicine, Oncology, Pharmacology +14
Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant
Grant D. MacLean, Mark A. Reddish, R. Rao Koganty et al. · Cancer Immunology Immunotherapy · 1993 · 183 citations · Full text
Medicine, Immunology, Oncology +16
Long-term safety of aromatase inhibitors in the treatment of breast cancer
J.-M. Nabholtz · Therapeutics and Clinical Risk Management · 2008 · 70 citations · Full text
Medicine, Oncology, Pharmacology +17
Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III study
Xavier Pivot, Thomas Suter, J.-M. Nabholtz et al. · European Journal of Cancer · 2015 · 69 citations
Medicine, Cardiology, Pharmacology +17
345 A multicenter, randomized study of two schedules of paclitaxel (PTX) in patients with advanced breast cancer (ABC)
Tamar Peretz, Aarón Sulkes, P. Chollet et al. · European Journal of Cancer · 1995 · 39 citations
Medicine, Oncology, Pharmacology +10
1–5 of 12